This overexpression is confirmed by the study of Rebbeck (Rebbeck et al., 2009) that reported FGFR2 over expression occurs in 10-15% of breast tumors, but FGFR2 expression is lower in normal breast tissue in someone who has T allele (Sun et al., 2010). Here, FGFR2 is linked to breast neoplasm.